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Intraperitoneal Photodynamic Therapy Causes a
Capillary-Leak Syndrome
Robert J. Canter, MD, Rosemarie Mick, MS, Susan B. Kesmodel, MD, Dan J. Raz, MD,
Francis R. Spitz, MD, James M. Metz, MD, Eli J. Glatstein, MD,
Stephen M. Hahn, MD, and Douglas L. Fraker, MD
Background: In patients undergoing intraperitoneal (IP) photodynamic therapy (PDT), the
combination of aggressive surgical debulking and light therapy causes an apparent systemic
capillary-leak syndrome that necessitates significant intensive care unit (ICU) management after
surgery.
Methods: From May 1997 to May 2001, 65 patients underwent surgical debulking and PDT as
part of an ongoing phase II trial for disseminated IP cancer. Perioperative data were reviewed
retrospectively, and statistical analyses were performed to determine whether any identifiable
factors were associated with the need for mechanical ventilation for longer than 1 day and with the
occurrence of postoperative complications.
Results: Forty-three women and 22 men (mean age, 49 years) were treated. Operative time
averaged 9.8 hours, and mean estimated blood loss was 1450 mL. The mean crystalloid requirement
for the first 48 hours after surgery was 29.3 L, and 49 patients required blood products. Twenty-four
patients were intubated for longer than 24 hours, with a mean of 8.3 days for those intubated longer
than 1 day. The median ICU stay was 4 days. Overall, 110 complications developed in 45 (69%) of
the 65 patients. Significant complications included 6 patients with acute respiratory distress
syndrome, 28 patients with infectious complications, and 4 patients with anastomotic complications.
Statistical analyses revealed that surgery-related factors were significantly associated with these
complication outcomes.
Conclusions: Patients who undergo surgical debulking and IP PDT develop a significant
capillary-leak syndrome after surgery that necessitates massive volume resuscitation, careful ICU
monitoring, and, frequently, prolonged ventilatory support.
Key Words: Photodynamic therapy—Carcinomatosis—Sarcomatosis—Capillary-leak syndrome.
Peritoneal carcinomatosis and sarcomatosis are gener-
ally incurable diseases for which few effective treatment
options exist.1–3 However, because of their tendency to
remain as regional diseases, as well as the significant
attendant patient morbidity, an aggressive approach to
these conditions is indicated. In an effort to better treat
this group of patients, several management strategies
have evolved, including aggressive debulking combined
with systemic chemotherapy (principally for ovarian
cancer), debulking with continuous hyperthermic perito-
neal perfusion (CHPP), immunotherapy, and photody-
namic therapy (PDT). Introduced clinically in 1985, PDT
is an anticancer treatment that combines a photosensi-
tizer drug, oxygen, and laser light to produce cytotoxic
reactive oxygen species.4–6 Photosensitizing agents are
thought to accumulate preferentially in tumor cells,
thereby making PDT-induced damage selective for ma-
lignant cells.7,8 Debulking is an important component of
this therapy, because light penetration with currently
available sensitizers is limited to 5 mm.
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A phase II trial of surgery and intraoperative PDT for
diffuse peritoneal cancers is under investigation at our
institution. Although the trial is ongoing and follow-up is
limited, preliminary results have been encouraging, with
an overall median survival to date of 21 months and
several patients who continue to have prolonged disease-
free survival.9 It has become apparent, however, that
patients who undergo this treatment develop a significant
inflammatory response syndrome after surgery that ne-
cessitates massive fluid resuscitation, careful intensive
care unit (ICU) monitoring, and, frequently, mechanical
ventilation of several days’ duration, all in excess of
what would be expected from major abdominal surgery
alone. This study was performed to describe this capil-
lary-leak syndrome in the context of PDT and to char-
acterize the complex nature of the postoperative manage-
ment of this group of patients. In addition, univariate and
multivariate statistical analyses were performed to iden-
tify the relation of individual patient- and surgery-related
factors to the development of this syndrome.
METHODS
Patient Selection
From May 1997 to May 2001, 65 patients underwent
surgical debulking and PDT as part of a phase II trial for
disseminated intraperitoneal (IP) cancer. The following
three criteria for patient selection were used: (1) carci-
nomatosis or sarcomatosis of any type; (2) absence of
extraperitoneal disease confirmed clinically and by
cross-sectional imaging, positron emission tomography,
or both; and (3) the ability to debulk all tumor nodules to
5 mm thickness before laser delivery. Because perito-
neal-based seeding of malignant disease is often difficult
to diagnose by noninvasive means, the ultimate determi-
nation of the ability to debulk all tumor nodules to 5
mm thickness was made during surgery by visual inspec-
tion of all peritoneal surfaces. Consequently, during this
4-year period, 23 patients were enrolled in the trial,
received photosensitizer, and underwent surgery but
were not able to be debulked to a residual tumor thick-
ness of 5 mm. These patients received palliative sur-
gical intervention without light therapy and were ex-
cluded from this analysis.
Exclusion criteria included cirrhosis, grade 3 to 4 liver
function test increases (i.e., values 2.5 times the upper
limit of normal), serum bilirubin 1.5 mg/dL, white
blood cell count 2000/mm3, platelet count 100,000/
mm3, creatinine 2.5 mg/dL, a history of ulcerative
colitis, a positive human immunodeficiency virus test,
pregnancy, and active lactation. All patients provided
informed, written consent, and the trial was approved by
the Institutional Review Board of the University of Penn-
sylvania, the Clinical Trials Scientific Review and Mon-
itoring Committee of the University of Pennsylvania
Cancer Center, and the Food and Drug Administration.
Treatment Protocol
The photosensitizer Photofrin (QLT Phototherapeutics
Ltd., Vancouver, British Columbia, Canada) was admin-
istered intravenously at a dose of 2.5 mg/kg, 48 hours
before laparotomy. After this, patients were at risk for
phototoxicity for 4 to 6 weeks, so direct sun exposure
was prohibited, and indirect light exposure was limited to
less than 8 hours per day of nonincandescent light. Dur-
ing surgery, the operating room lights and surgeon head-
lamps were covered with filter paper to minimize non-
specific activation of the photosensitizer. In addition, the
patient’s skin was covered with Ioban (3M, St. Paul,
MN) drapes, and intermittent pulse oximetry monitoring
was used to prevent phototoxicity. For those patients in
whom a pulmonary artery catheter was inserted, a non-
oximetric catheter was placed because of similar con-
cerns for potential phototoxicity.
At laparotomy, tumor debulking, in combination with
organ resection when necessary, was performed to re-
move all disease 5 mm in thickness. Peritoneal strip-
ping was performed to remove macroscopic tumor nod-
ules only. The operative procedure also included
complete lysis of adhesions and bowel mobilization to
permit exposure and light delivery to all peritoneal sur-
faces. Laser light was delivered by the radiation oncol-
ogy and physics team by using doses and wavelengths as
described elsewhere.9–11 After light therapy, the abdo-
men was copiously irrigated, bowel anastomoses and
stoma maturation were performed as necessary, and fas-
cial closure was completed.
All patients were taken to the ICU after surgery, with
strict light precautions as noted previously. Invasive
monitoring included an arterial line, Foley catheter, and
central venous line, placed during surgery in all patients.
Swan-Ganz catheters were not routinely inserted. Post-
operative fluid resuscitation was guided primarily by
urine output, targeting an hourly output of .5 to 1.0
mL/kg/hour. Goal mean arterial pressure was 65 mm
Hg, and intravenous fluid was given as first-line therapy
to maintain this target, except where further fluid admin-
istration was considered contraindicated (e.g., central
venous pressure 12 mm Hg). In the ICU, patient care
decisions were made by the primary operating team in
consultation with a critical care team composed of sur-
geons and anesthesiologists.
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Data Collection and Statistical Analysis
Patient charts were reviewed retrospectively with at-
tention to data detailing the surgical procedure, the
amount of crystalloid and colloid administered (particu-
larly within the 48 hours after surgery), the duration of
ICU and overall hospital stay, and the presence and
severity of postoperative complications. Complications
were grouped by organ system, and for purposes of data
abstraction, the following criteria were used. To deter-
mine the presence of acute respiratory distress syndrome
(ARDS), the American-European consensus definition
was used: namely, an alveolar-arterial difference in par-
tial pressure of oxygen–fraction of inspired oxygen ratio
of 200, bilateral opacities on the chest radiograph, and
either a pulmonary artery wedge pressure of18 mm Hg
or the absence of clinical evidence of left atrial hyper-
tension.12 The diagnosis of pulmonary embolism was
made on the basis of ventilation/perfusion scanning
and/or high-resolution spiral computed tomography of
the chest given an appropriate clinical index of suspicion.
Pneumonia was diagnosed if three or more of the fol-
lowing criteria were present: new or increased oxygen
requirement, new infiltrate on chest radiography, fever,
purulent secretions or sputum, or positive microbiologi-
cal examination of tracheal or bronchoscopic aspirates.
Criteria for diagnosing the presence of infectious com-
plications included a temperature of 38.6°C and posi-
tive microbiological cultures (from blood, urine, sputum,
or catheter tip) along with the presence of white blood
cells on Gram stain. Positive microbiological data were
not considered necessary to confirm the presence of an
intra-abdominal abscess, because many patients were
already receiving antibiotic therapy at the time of percu-
taneous drainage. A wound infection was identified if
erythema or drainage was present that necessitated open-
ing the wound with institution of local wound care,
irrespective of any other clinical factors.13 All other
complications were classified according to established
clinical and radiological criteria.
Statistical analysis was used to determine whether any
patient- or surgery-related factors were associated with
the need for mechanical ventilation for longer than 1 day
or with a risk of postoperative pulmonary complications.
Although we collected data on overall complication
rates, we chose not to subject this outcome to similar
statistical analysis because the heterogenous nature of
these complications precluded meaningful conclusions.
The other outcomes were chosen for analysis because the
need for mechanical ventilation for longer than several
hours after major abdominal surgery is considered de-
cidedly abnormal and because pulmonary complications,
particularly ARDS, are considered potential markers of
the systemic inflammatory response syndrome (SIRS).14
Pulmonary complications included ARDS, pleural effu-
sion, pneumonia, and reintubation. In addition, several
postsurgery factors (e.g., liters of IV fluids and blood or
blood-product transfusions) were described but not eval-
uated as predictors of complications because these fac-
tors were measured during the first 48 hours after surgery
and, as such, were concurrent with the symptomatic or
asymptomatic onset of many complications. Complica-
tion rates and 95% confidence intervals were calculated.
Coefficient of variation percentage (CV%  [SD/mean]
 100) was also used to judge interpatient variation, with
CV% 35% indicating minimal variation and CV%
75% indicating substantial variation.
Continuous factors, such as age in years and surgery
duration in hours, were examined as both continuous and
categorical variables. Each continuous factor was re-
coded into a three-level ordinal factor (low, intermediate,
or high) on the basis of 33rd percentiles. Associations
between patient- and surgery-related factors and compli-
cation rates were tested by Fisher’s exact test (nominal
factors), an exact linear trend test (ordinal factors), or
logistical regression (continuous factors). Fisher’s exact
test was used to test for differences in complication rates
across levels of a nominal factor (e.g., sex). The linear
trend test was used to test for increasing or decreasing
complication rates by increasing levels of an ordinal
factor. Because of a priori hypotheses that more aggres-
sive surgery (e.g., more nodules removed) and worse
baseline health (e.g., greater body mass index) would be
associated with higher complication rates, a one-sided
trend test was performed.
Multivariate logistical regression modeling was used
to investigate the simultaneous effects of patient- and
surgery-related factors on the probability of experiencing
a complication.15 Modeling using both forward selection
and backward elimination of factors was performed.
Because we investigated several surgery-related factors
that were strongly associated with both the outcomes and
with each other, forward and backward strategies en-
abled us to avoid redundancy in constructing models of
significant independent predictors of postsurgical com-
plications. A likelihood ratio test was used to either
select or eliminate factors. Candidate factors included
age, sex, diagnosis, prior operations, body mass index,
number of organs resected, number of nodules removed,
surgery duration, and estimated blood loss. Number of
nodules removed, surgery duration, and estimated blood
loss were evaluated as both continuous and categorical
factors because each was significant in univariate anal-
ysis. Only patients with complete data on all factors were
included in the stepwise modeling. Once the final model
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was defined, it was refit to patients with data on the final
factors. Odds ratio estimates with 95% confidence inter-
vals and asymptotic (Wald) significance tests of factors
are presented in the final models.16 The odds ratio char-
acterizes the magnitude of the increased risk of a com-
plication for each unit increase of a particular risk factor.
Because assumptions for asymptotic testing may not
hold for small or highly imbalanced data sets, exact
significance tests were also performed.17
Descriptive and cross-tabulation analyses, estimation
of complication rates, and logistical regression modeling
were performed in SPSS 9.0 (SPSS Inc., Chicago, IL).
Exact linear trend tests and Fisher’s exact tests were
performed in StatXact 4.0 (Cytel Software Corp., Cam-
bridge, MA). Logistical regression modeling with exact
significance testing was performed in LogXact (Cytel
Software Corp.). Two-sided P values are reported for all
tests, with the exception of one-sided linear trend tests,
as noted. A P value of .05 was considered statistically
significant.
RESULTS
Patient Characteristics
The characteristics of the patient group are listed in
Table 1. There were 43 women and 22 men with a mean
age  SD of 48.8  10.2 years. Twenty-five patients
(39%) had a diagnosis of sarcomatosis, of whom 12 had
gastrointestinal stromal tumors, 4 had uterine leiomyo-
sarcomas, 1 had a liposarcoma, 1 had a synovial sar-
coma, and 7 had unclassified sarcomas. There were 19
patients (29%) with ovarian cancer. Of the 17 patients
(26%) with a gastrointestinal malignancy, 8 had a co-
lonic primary tumor, 6 had appendiceal primary tumors,
2 had gastric primary tumors, and 1 had an unspecified
primary lesion. In addition, there were two patients with
primary peritoneal cancer (grouped with ovarian for pur-
poses of statistical evaluation), one with abdominal me-
sothelioma, and one with a diffuse carcinoid tumor.
The mean number of prior laparotomies for the study
group was 2.3 1.2 operations (range, 0–5). One patient
was taken to the operating room without any prior oper-
ations. He presented with progressive abdominal disten-
sion and was found to have pronounced omental thick-
ening and extensive ascites on a computed tomographic
scan. Subsequent diagnostic paracentesis was positive
for adenocarcinoma with signet-ring features.
The mean body mass index of the patients was 25.4 
5.3 kg/m2 (range, 16.2–44.8 kg/m2). Medical history was
relatively unremarkable in this group of patients. Thir-
teen patients had hypertension, four had hypothyroidism,
two had type II diabetes mellitus, two had chronic atrial
fibrillation, two had asthma, one had coronary artery
disease, and one had sleep apnea. Forty-four patients
(68%) had previously received chemotherapy for their
cancer, and two patients had undergone bone marrow
transplantation.
Intraoperative Factors
The data indicating the extent of operation are listed in
Table 1. The mean  SD number of organs resected per
patient was 2.3  1.4. The distribution of the organ
resections is shown in Fig. 1. The most frequently re-
sected organs were omentum, small intestine, and large
intestine in 30 patients each (46%). The number of tumor
nodules varied considerably among patients, with a mean
number of nodules per patient of 80  181, a median of
20 (range, 1–1000), and a CV% of 225%. Nodule size
also varied widely among the patients, with implants
ranging in size from 100 mg to a 6-kg mass. Estimated
blood loss, as recorded by the attending surgeon, was
also highly variable, with a mean of 1446  1241 mL, a
median of 1000 (range, 100–5000 mL), and a CV% of
86%. In contrast, surgery duration was much less vari-
able (CV%, 25%); operating time averaged 9.8  2.5
hours per patient, including approximately 3 hours for
the laser therapy.
TABLE 1. Patient- and surgery-related characteristics of
the study group
Characteristic Mean  SD n (%)
Age (y) 48.8  10.2
Sex
Female 43 (66)
Male 22 (34)
Diagnosis
Sarcoma 25 (39)
Ovariana 21 (32)
GIb 17 (26)
Otherc 2 (3)
Prior abdominal operations 2.3 1.2
Body mass index (kg/m2) 25.4  5.3
Surgery duration (h) 9.8 2.5
Nodules removed 80 181
Organs resected 2.3 1.4
Estimated blood loss (mL) 1446 1241
Crystalloid first 48 h after surgery (L) 29.3  12.4
Red blood cells, first 48 h after
surgery (units)
3.9  4.1
Fresh-frozen plasma first 48 h after
surgery (units)
2.5  3.7
Platelets first 48 h after surgery
(units)
.9  2.6
GI, gastrointestinal.
a Includes two primary peritoneal adenocarcinomas.
b Includes eight colonic, six appendiceal, and two gastric carcinomas
and one adenocarcinoma of unknown primary origin.
c Includes one abdominal mesothelioma and one carcinoid.
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Postoperative Course
Fluid requirements for the patients during the first
48 hours are listed in Table 1. The mean  SD volume
of crystalloid infused per patient was 29.3  12.4 L
(range, 10 –90 L). Forty-five patients (69%) were
transfused with an average of 5.4 units of packed red
blood cells each (range, 1–17 units). Fresh-frozen
plasma was administered to 30 patients (46%), with a
mean of 5.3 units per patient transfused (range, 1–15
units). Seven patients (11%) received platelet transfu-
sions, averaging 1.3 six-packs per patient transfused
(range, 1–2). Given these extensive volume require-
ments, patients typically experienced a dramatic pos-
itive fluid balance within the first 48 hours, which was
followed by a diuresis over the next 5 days, gradually
returning to a net even fluid balance at day 7. Patients
typically developed anasarca during the initial period
of positive fluid balance. Although this condition im-
proved over time, it sometimes took weeks to resolve
completely.
Thirty-nine patients (60%) were extubated within 24
hours, 24 patients (38%) were intubated for longer than
1 day, and data on extubation were unavailable for 2
patients (Fig. 2A). Overall, the median duration of post-
operative mechanical ventilation was 1 day (range, 0–25
days). However, for those patients intubated for longer
than 1 day, the mean  SD duration of mechanical
ventilation was 8.3  6.8 days. The median ICU stay
(Fig. 2B) was 4 days (range, 1–40 days), with patients
typically remaining in the ICU 48 to 72 hours after
extubation for close monitoring of their pulmonary and
fluid status. The median time to resumption of a liquid
diet was 6 days (range, 3–30 days), and the median
hospital stay (Fig. 2C) was 11 days (range, 5–57 days),
with all but two patients being discharged directly to
home.
FIG. 1. Distribution of organ resections among study patients.
FIG. 2. (A) Distribution of days of ventilation among study patients. (B)
Distribution of days in the intensive care unit (ICU) among study patients.
(C) Distribution of length of hospital stay among study patients.
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Postoperative Complications
The one postoperative death (i.e., 30 days) in this
series occurred in a 63-year-old patient with abdominal
mesothelioma who had a history of coronary artery dis-
ease and had previously undergone right coronary artery
stenting. Within the first 48 hours after surgery, he de-
veloped hypotension refractory to massive fluid resusci-
tation (48 L of crystalloid), requiring the institution of
pressors. Pulmonary artery catheter monitoring was con-
sistent with septic physiology. A leukocytosis of 35,000
white blood cells per cubic millimeter developed by
postoperative day 4, and cultures eventually revealed
Gram-negative rods in his sputum and blood. He subse-
quently developed ARDS, as well as liver, renal, and
cardiac failure, and died on postoperative day 17. Post-
mortem analysis revealed diffuse lung consolidation,
biventricular cardiac dilatation with a 1.2-cm area of
hemorrhage in the left ventricle consistent with acute
infarction, a congested liver and kidneys, and ascites.
Overall, 110 complications developed in 45 (69%) of
the 65 patients (95% confidence interval, 58%–80%).
Table 2 lists the incidence of complications by organ
system. The principal complications were pulmonary,
infectious, and gastrointestinal. Twenty-four pulmo-
nary complications developed in 17 (26%) of the 65
patients (95% confidence interval, 15%–37%). Six
patients developed ARDS, on the basis of consensus
criteria. In five of these patients, ARDS was an early
postoperative complication, developing within 48 to
72 hours. Conversely, one patient developed ARDS on
postoperative day 7 after reintubation for respiratory
failure secondary to pneumonia. ARDS was treated
with a number of ventilation strategies; three patients
were managed with low–tidal volume ventilation, two
with pressure-control ventilation, and one with a com-
bination of pressure-control ventilation and inhaled
nitric oxide. In all but the patient who died, the syn-
drome resolved, and patients were successfully extu-
bated within 4 to 25 days.
Additional pulmonary complications included six pa-
tients who developed pleural effusions that were judged
clinically to be impairing the patients’ respiratory status
and were therefore drained, either by thoracentesis or
tube thoracostomy. Fifteen other patients had pleural
effusions documented by chest radiography. However,
their pulmonary status was considered stable enough not
to require drainage. Four patients developed pneumonia
that prolonged intubation or contributed to reintubation,
and two patients had pulmonary embolic events. Five
patients required reintubation, one of whom was reintu-
bated on two separate occasions.
Forty infectious complications were identified in 26
(40%) of the 65 patients (95% confidence interval, 28%–
52%), including 12 catheter-related infections, 10 wound
infections, 8 intra-abdominal abscesses, and 8 urinary
tract infections. One patient developed Clostridium dif-
ficile colitis, which resolved with enteral metronidazole,
and one patient with persistent diarrhea was diagnosed
with cytomegalovirus colitis after colonoscopic exami-
nation. She was successfully treated with ganciclovir.
Significant gastrointestinal complications included
pancreatitis/pancreatic leak in three patients (two of
whom underwent distal pancreatectomy as part of their
debulking procedure), enterocutaneous fistulae in two
patients, and peritoneovaginal fistula in one patient. In
one patient, the enterocutaneous fistula was secondary to
an anastomotic leak, and reoperation was necessary. The
other enterocutaneous fistula closed with bowel rest and
total parenteral nutrition, and although the peritoneovagi-
nal fistula did not close, it was successfully managed
with conservative treatment.
Overall, two patients required reoperation (3%). In
addition to the patient who developed an anastomotic
TABLE 2. Complications by organ system
Organ system Complication
No.
Affected
Pulmonary Reintubation 6
Acute respiratory distress
syndrome
6
Effusion requiring drainage 6
Pneumonia 4
Pulmonary embolism 2
Infectious Central line 12
Wound 10
Urinary tract 8
Intra-abdominal abscess 8
Clostridium difficile colitis 1
Cytomegalovirus colitis 1
Gastrointestinal Pancreatitis/pancreatic leak 3
Enterocutaneous fistula 2
Anastomotic leak 1
Peritoneovaginal fistula 1
Central nervous system Delirium 3
Confusion 2
Seizures 1
Cardiac Atrial fibrillation/supraventricular
tachycardia
6
Ventricular tachycardia 1
Hematological Thrombocytopenia
(platelets 50,000/mm3)
5
Coagulopathy (INR 2) 3
Renal Hydronephrosis 3
Bladder injury 2
Acute tubular necrosis/acute
renal failure
1
Other Phototoxicity 8
Deep vein thrombosis 2
Femoral neuropraxia 1
Sacral ulcer 1
INR, international normalized ratio.
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leak, there was another patient whose abdominal fascia
could not be closed at the time of the initial operation
because of bowel edema. She was kept paralyzed and
sedated with a sterile dressing covering an open abdo-
men until postoperative day 4, at which time she was
returned to the operating room and her fascia was suc-
cessfully closed.
Univariate and Multivariate Analysis
The results of univariate analyses of patient and
surgical factors in relation to the need for mechanical
ventilation for longer than 1 day and the presence of
pulmonary complications are listed in Tables 3 and 4,
respectively. These two outcomes were selected for
analysis because in the absence of significant preex-
isting pulmonary comorbidity, as in our study group,
the need for prolonged mechanical ventilation and the
occurrence of pulmonary complications, such as acute
lung injury and ARDS, are considered putative mark-
ers of the SIRS.14 By univariate analysis, we deter-
mined that indicators of more aggressive surgery were
significantly associated with higher rates of complica-
tions. A greater number of nodules removed, longer
surgery duration, and higher estimated blood loss were
all significantly associated (P  .05) with a higher rate
both of mechanical ventilation for longer than 1 day
and of pulmonary complications. A weaker associa-
tion (P  .06) was observed between a greater number
of organs resected and the risk of mechanical ventila-
tion for longer than 1 day.
TABLE 3. Univariate analysis of ventilation 1 day
Variable
No. Patientsa
(N  63)
No. With
complication
(N  24)
%
(N  38.1)
P
value
Age (y)
45 22 7 31.8
45–54 22 8 36.4 .20b
55 19 9 47.4
Sex
Male 22 6 27.3 .28c
Female 41 18 43.9
Diagnosis
Sarcoma 25 7 28.0 .29c
Ovarian 21 8 28.1
GI 16 8 50.0
Other 1 1 100.0
Prior operations
0–1 16 8 50.0
2 22 8 36.4 .13b
3 24 7 29.2
Body mass index (kg/m2)
22.5 18 6 33.3
22.5–27.0 20 10 50.0 .49b
27.0 19 7 36.8
Organs resected
0–1 19 5 26.3
2–3 32 12 37.5 .06b
4 12 7 58.3
Nodules removed
0–10 28 7 25.0
11–100 21 10 47.6 .025b
100 12 7 58.3
Surgery duration (h)
5–8 24 6 25.0
8.5–10.5 16 4 25.0 .009b
11 23 14 60.9
Estimated blood loss (mL)
100–700 22 3 13.6
800–1500 20 11 55.0 .015b
1500 21 10 47.6
GI, gastrointestinal.
a Because complete data were not available on all patients for each factor, certain rows sum to 63.
b P value from one-sided exact linear trend test.
c P value from Fisher’s exact test.
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The results of multivariate analyses are listed in Table
5. By forward selection and backward elimination logis-
tical regression analyses, we determined that longer sur-
gery duration was highly significantly associated with a
risk of ventilation for longer than 1 day. After adjusting
for surgery duration, female sex also demonstrated an
association with this complication, but the association
did not reach statistical significance. A greater number of
nodules removed and larger body mass index, defined as
continuous factors, were both significantly associated
with a greater risk of pulmonary complications.
DISCUSSION
SIRS has become a well-recognized, albeit poorly
defined, entity that occurs in many clinical settings,
including burns, sepsis, pancreatitis, and after cardiopul-
monary bypass.18,19 It is typically characterized by in-
creased vascular permeability, which simultaneously
leads to intravascular volume depletion and tissue
edema. In severe cases, it can progress to ARDS, shock,
and multiorgan failure. Although a consensus has not
emerged to explain the sequence of events at the molec-
ular and cellular levels, SIRS is believed to occur when
proinflammatory mediators, such as tumor necrosis fac-
tor-, interleukin-1, and interleukin-8, stimulate an ex-
aggerated response from immune effector cells, such as
neutrophils, dendritic cells, and macrophages.20,21 Ongo-
ing proinflammatory cytokine production from these ef-
fector cells then presumably leads to propagation and
amplification of this inflammatory cascade, with result-
ant end-organ manifestations.18,22 Ischemia/reperfusion
TABLE 4. Univariate analysis of presence of pulmonary complications
Variable
No. Patientsa
(N  65)
No. With
complication
(N  17)
%
(N  26.2)
P
value
Age (y)
45 23 6 26.1
45–54 23 6 26.1 .56b
55 19 5 26.3
Sex
Male 22 7 31.8 .55c
Female 43 10 23.3
Diagnosis
Sarcoma 25 4 16.0 .43c
Ovarian 21 6 28.6
GI 17 6 35.3
Other 2 1 50.0
Prior operations
0–1 16 7 43.8
2 22 4 18.2 .09b
3 25 5 20.0
Body mass index (kg/m2)
22.5 19 4 21.1
22.5–27.0 21 7 33.3 .30b
27.0 19 6 31.6
Organs resected
0–1 19 3 15.8
2–3 32 9 28.1 .11b
4 13 5 38.5
Nodules removed
0–10 28 4 14.3
11–100 21 7 31.8 .015b
100 12 6 50.0
Surgery duration (h)
5–8 24 3 12.5
8.5–10.5 16 4 25.0 .02b
11 24 10 41.7
Estimated blood loss (mL)
100–700 22 2 9.1
800–1500 21 8 38.1 .05b
1500 21 7 33.3
GI, gastrointestinal.
a Because complete data were not available on all patients for each factor, certain rows sum to 65.
b P value from one-sided exact linear trend test.
c P value from Fisher’s exact test.
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and host-cell apoptosis, particularly of lymphocytes and
intestinal epithelial cells, are considered important me-
diators of the SIRS pathway because the release of oxi-
dants and cellular degradative enzymes likely contributes
to end-organ injury.23,24 The variability in the develop-
ment and expression of SIRS among patients reflects the
complexity of the interaction between the various exog-
enous inflammatory insults that initiate SIRS and the
host’s response to these stimuli.
Our study demonstrates that extensive surgical de-
bulking combined with IP PDT is another clinical
scenario in which a pronounced capillary-leak syn-
drome occurs. The complicated postoperative course
observed in this group of patients, exemplified by the
massive fluid requirements, the increased need for
prolonged mechanical ventilation, and the high inci-
dence of pulmonary complications, is rarely observed
after major abdominal surgery alone. In this way, the
clinical course of patients after IP PDT resembles that
of patients with extensive cutaneous burns, who are
susceptible to profound SIRS. This similarity is un-
derstandable if the light therapy of PDT is analogous
to thermal energy, especially in view of the extensive
surface area of the peritoneal cavity. This burn equiv-
alent, in the context of a major abdominal surgical
procedure, likely stimulates the production of proin-
flammatory cytokines that then cause the significant
capillary-leak syndrome and the consequent high in-
cidence of postoperative complications observed in
these patients. In addition, because the generation of
oxygen free radicals and the induction of apoptosis in
tumor vasculature are important components of PDT-
induced cell killing,5,6 these same mechanisms may
also be active in initiating and promoting the SIRS
response after IP PDT.
It is difficult to determine whether the capillary-leak
syndrome in these patients can be attributed solely to
PDT. Statistical analysis of our study group did reveal
strong associations between intraoperative factors (i.e.,
factors indicating a more extensive surgical procedure,
such as surgery duration and the number of nodules
removed) and both the need for mechanical ventilation
for longer than 1 day and the occurrence of pulmonary
complications. This likely indicates that the extensive
abdominal surgery required to successfully debulk these
patients contributes to the postoperative capillary-leak
syndrome. Although only 2 of the patients in our study
group received 15 units of packed red blood cells (the
perceived threshold for massive transfusion-induced
ARDS),19 the degree of extensive surgical debulking
required in this patient group a priori led to longer
anesthesia times, increased fluid shifts, and greater trans-
fusion requirements. In this way, the capillary-leak syn-
drome in this group of patients may reflect the accumu-
lation of multiple inflammatory insults from the
combination of the patients’ disease state, the surgical
procedure, and the light therapy.
The evidence available in the literature tends to sup-
port our view that the capillary-leak syndrome after IP
PDT is more prevalent and pronounced than that after
extensive abdominal surgery alone. In the phase I trial of
IP PDT, the authors also noted the presence of significant
pulmonary complications attributable to a capillary-leak
syndrome, including pleural effusions in 59% of patients,
pleural effusion requiring drainage in 15% of patients,
and prolonged ventilator dependence in 9% of patients.10
Conversely, although hepatectomy, pancreaticoduode-
nectomy, and esophagectomy are major gastrointestinal
operations that can have similar duration and blood loss,
the postoperative course of patients undergoing these
procedures is rarely notable for the same degree of
SIRS.25–27
Patients treated with CHPP, which combines aggres-
sive surgical debulking with the regional circulation of
chemotherapy for patients with carcinomatosis, may be
the most analogous to our study group. Although recent
analyses of morbidity and mortality after CHPP have
shown a 30-day mortality rate of 1.5% to 6% and an
overall morbidity rate of 27% to 35%, there does not
seem to be the same tendency for profound SIRS after
CHPP as after IP PDT.28,29 In a report of 183 patients
treated with CHPP, Stephens et al.29 noted a 9% inci-
dence of National Cancer Institute grade III/IV pulmo-
nary complications and an additional 3% incidence of
TABLE 5. Multivariate analysis of types of complications
Complication
type Risk factors in final model
Odds
ratio 95% CI
Asymptotic
P value
Exact
P value
Ventilation 1 d Longer surgery durationa 1.47 1.13–1.92 .004 .001
Female sex 3.15 .89–11.11 .07 .12
Pulmonary More nodules removeda 2.87 1.16–7.09 .02 .04
Higher body mass indexa 1.16 1.01–1.34 .04 .02
CI, confidence interval.
a Coded as continuous factors.
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pleural effusion requiring thoracentesis. In our series,
National Cancer Institute grade III/IV pulmonary com-
plications occurred in 26% of patients. ARDS has also
been observed after CHPP in the absence of other iden-
tifiable precipitating factors, but the incidence of this
complication is a rarer event after CHPP than after IP
PDT.30 In addition, although CHPP using an open coli-
seum technique has been associated with extensive fluid
requirements to maintain adequate cardiac function and
urine output, this was limited to the intraoperative period
only and did not persist into the postoperative period, as
with our IP PDT patients.31 Studies such as these rein-
force our conclusion that IP PDT is a necessary compo-
nent of the capillary-leak syndrome beyond that of ex-
tensive abdominal surgery alone.
In conclusion, IP PDT is associated with a significant
postoperative capillary-leak syndrome. Although this
syndrome is likely multifactorial in etiology, patients
undergoing IP PDT require massive volume resuscitation
to a degree greater than that after major abdominal sur-
gery alone. As a result, these patients need careful ICU
monitoring and, frequently, prolonged ventilatory sup-
port and are susceptible to significant postoperative com-
plications, particularly those of a pulmonary nature. Nev-
ertheless, despite the complexity of the perioperative
management after IP PDT, we continue to advocate this
treatment modality as part of an ongoing, monitored
phase II trial for appropriately selected patients with
diffuse peritoneal malignancies who have limited mean-
ingful treatment options.
ACKNOWLEDGMENTS
The acknowledgments are available online at
www.annalssurgicaloncology.org.
REFERENCES
1. Berek JS, Bertelsen K, du Bois A, et al. Advanced epithelial
ovarian cancer: 1998 consensus statements. Ann Oncol 1999;
10(Suppl 1):87–92.
2. Schellinx ME, von Meyenfeldt MF, Sugarbaker PH. Peritoneal
carcinomatosis from adenocarcinoma of the colon. Cancer Treat
Res 1996;81:247–60.
3. Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influ-
encing survival in gastrointestinal leiomyosarcomas. Implications
for surgical management and staging. Ann Surg 1992;215:68–77.
4. Benson RC Jr. Laser photodynamic therapy for bladder cancer.
Mayo Clin Proc 1986;61:859–64.
5. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic
therapy. J Natl Cancer Inst 1998;90:889–905.
6. Oleinick NL, Evans HH. The photobiology of photodynamic ther-
apy: cellular targets and mechanisms. Radiat Res 1998;150(5 Sup-
pl):S146–56.
7. Gomer CJ, Dougherty TJ. Determination of [3H]- and [14C]hema-
toporphyrin derivative distribution in malignant and normal tissue.
Cancer Res 1979;39:146–51.
8. Peng Q, Soler AM, Warloe T, et al. Selective distribution of
porphyrins in skin thick basal cell carcinoma after topical appli-
cation of methyl 5-aminolevulinate. J Photochem Photobiol B
2001;62:140–5.
9. Hendren SK, Hahn SM, Spitz FR, et al. Phase II trial of debulking
surgery and photodynamic therapy for disseminated intraperitoneal
tumors. Ann Surg Oncol 2001;8:65–71.
10. DeLaney TF, Sindelar WF, Tochner Z, et al. Phase I study of
debulking surgery and photodynamic therapy for disseminated
intraperitoneal tumors. Int J Radiat Oncol Biol Phys 1993;25:445–
57.
11. Sindelar WF, DeLaney TF, Tochner Z, et al. Technique of photo-
dynamic therapy for disseminated intraperitoneal malignant neo-
plasms. Phase I study. Arch Surg 1991;126:318–24.
12. Bernard GR, Artigas A, Brigham KL, et al. The American-Euro-
pean Consensus Conference on ARDS. Definitions, mechanisms,
relevant outcomes, and clinical trial coordination. Am J Respir Crit
Care Med 1994;149(3 Pt 1):818–24.
13. Gurevich I. Surgical site infections: simplifying the definitions.
Infect Control Hosp Epidemiol 1995;16:667–8.
14. Bone RC. Immunologic dissonance: a continuing evolution in our
understanding of the systemic inflammatory response syndrome
(SIRS) and the multiple organ dysfunction syndrome (MODS).
Ann Intern Med 1996;125:680–7.
15. Lemeshow S, Hosmer DW Jr. Estimating odds ratios with cate-
gorically scaled covariates in multiple logistic regression analysis.
Am J Epidemiol 1984;119:147–51.
16. Vollset SE, Hirji KF, Afifi AA. Evaluation of exact and asymptotic
interval estimators in logistic analysis of matched case-control
studies. Biometrics 1991;47:1311–25.
17. Hirji KF, Elashoff RM, Moore DH II, Bennett DE. Exact versus
asymptotic analysis for a matched case-control study. Stat Med
1988;7:765–72.
18. Bone RC. Toward a theory regarding the pathogenesis of the
systemic inflammatory response syndrome: what we do and do
not know about cytokine regulation. Crit Care Med 1996;24:
163–72.
19. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure:
role of extrathoracic injury and sepsis in adult respiratory distress
syndrome. New Horiz 1993;1:538–49.
20. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling—
regulation of the immune response in normal and critically ill
states. Crit Care Med 2000;28(4 Suppl):N3–12.
21. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus
anti-inflammatory cytokine profile in patients with severe sepsis: a
marker for prognosis and future therapeutic options. J Infect Dis
2000;181:176–80.
22. Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in
human septic shock. Relation to multiple-system organ failure and
mortality. Chest 1993;103:565–75.
23. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell
death in patients with sepsis, shock, and multiple organ dysfunc-
tion. Crit Care Med 1999;27:1230–51.
24. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL.
Apoptosis in sepsis: a new target for therapeutic exploration.
FASEB J 2001;15:879–92.
25. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-
seven hepatectomies in the 1990s: an update to evaluate the actual
risk of liver resection. J Am Coll Surg 2000;191:38–46.
26. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive
pancreaticoduodenectomies in the 1990s: pathology, complica-
tions, and outcomes. Ann Surg 1997;226:248–57; discussion 257–
60.
27. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagec-
tomy: clinical experience and refinements. Ann Surg 1999;230:
392–400; discussion 400–3.
28. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of mor-
bidity and mortality in 60 patients with peritoneal carcinomatosis
523INTRAPERITONEAL PDT CAUSES A CAPILLARY-LEAK SYNDROME
Ann Surg Oncol, Vol. 10, No. 5, 2003
treated by cytoreductive surgery and heated intraoperative intra-
peritoneal chemotherapy. Cancer 1996;77:2622–9.
29. Stephens AD, Alderman R, Chang D, et al. Morbidity and mor-
tality analysis of 200 treatments with cytoreductive surgery and
hyperthermic intraoperative intraperitoneal chemotherapy using
the coliseum technique. Ann Surg Oncol 1999;6:790–6.
30. Alonso O, Sugarbaker PH. Adult respiratory distress syndrome
occurring in two patients undergoing cytoreductive surgery plus
perioperative intraperitoneal chemotherapy: case reports and a
review of the literature. Am Surg 2000;66:1032–6.
31. Esquivel J, Angulo F, Bland RK, et al. Hemodynamic and cardiac
function parameters during heated intraoperative intraperitoneal
chemotherapy using the open “coliseum technique”. Ann Surg
Oncol 2000;7:296–300.
524 R. J. CANTER ET AL.
Ann Surg Oncol, Vol. 10, No. 5, 2003
